Helen of Troy (HELE) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
8 Jul, 2026Executive summary
Third quarter results met expectations, with consolidated net sales down 3.4% year-over-year to $512.8 million, reflecting disciplined execution amid a challenging environment and growth in Osprey, OXO, and Olive & June brands.
Olive & June exceeded expectations, contributing $37.7 million in quarterly sales and positively impacting segment performance.
Operating loss was $8.4 million for the quarter, with a net loss of $84.1 million, primarily due to $65.9 million in non-cash asset impairment charges.
Adjusted diluted EPS was $1.71, down from $2.67 in the prior year.
Key priorities include investing in innovation, optimizing spending, and managing the balance sheet to drive cash flow and reduce debt.
Financial highlights
Net sales revenue was $512.8 million for Q3 FY2026, down 3.4% year-over-year; gross profit margin decreased to 46.9% from 48.9%.
Adjusted operating margin was 12.9% (down from 16.6%); adjusted EBITDA margin was 14.7% (down from 18.2%).
Adjusted diluted EPS was $1.71; net loss was $84.1 million, compared to net income in the prior year.
Year-to-date free cash flow was $28.8 million, down from $56.1 million in the prior year.
Inventory increased to $505.3 million, including $35 million in higher tariff costs; total debt rose to $892.4 million.
Outlook and guidance
FY2026 net sales expected between $1.758 billion and $1.773 billion, down 7.1–7.8% year-over-year.
Adjusted EPS guidance is $3.25–$3.75; GAAP diluted loss per share forecasted at $(36.07) to $(35.57).
Home & Outdoor net sales projected at $812–$819 million; Beauty & Wellness at $946–$954 million, including $106–$109 million from Olive & June.
Margin pressure and revenue softness expected to persist due to tariffs, consumer trade-down, and increased competition.
Project Pegasus restructuring aims to deliver $75–$85 million in annualized pre-tax profit improvements by fiscal 2027.
Latest events from Helen of Troy
- Sales up 8.2% to $402.1M; GAAP EPS $1.51; 2027 outlook raised amid margin and cost pressures.HELE
Q1 20279 Jul 2026 - Q2 sales and margins fell, but guidance, cash flow, and $500M buyback remain on track.HELE
Q2 20259 Jul 2026 - Shareholders will vote on key governance, compensation, and equity plan changes amid ongoing transformation.HELE
Proxy filing24 Jun 2026 - Board recommends approval of all proposals, including director elections and compensation.HELE
Proxy filing24 Jun 2026 - Sales and margins fell on tariffs and impairments; FY27 targets recovery and debt reduction.HELE
Q4 202623 Apr 2026 - Prioritizing high-growth brands, revenue focus, and global expansion to drive long-term value.HELE
28th Annual ICR Conference 20263 Feb 2026 - Sales and earnings fell sharply, prompting lower guidance and continued restructuring.HELE
Q1 20253 Feb 2026 - All proposals passed as the company focuses on brand revitalization and operational transformation.HELE
AGM 202423 Jan 2026 - $240M acquisition of a high-growth nail brand, immediately accretive and diversifying the portfolio.HELE
M&A Announcement12 Jan 2026